Effects of Triptorelin on Adult Height in Girls with Precocious Puberty
Author Information
Author(s): Raquel Corripio, Leandro Soriano-Guillén, Francisco-Javier Herrero, Lidia Castro-Feijoó, Aránzazu Escribano, Paula Sol-Ventura, Rafael Espino, Amaia Vela, José-Ignacio Labarta, Ignacio Díez López, Rafael Ruiz Cano, José Pastor Rosado, Diego Esteban de Sotto, Nuria Cabrinety Perez, Diego Yeste Fernández, Larisa Suárez Ortega, Mariona Bonet Alcaina, Rosa Martín Ramos, Gertrudis Martí Aromir, Rosangela Tomasini, Gemma Carreras González, María Victoria Borrás Pérez, Meritxell Torrabías Rodas, Montserrat Roqueta Sureda, Marta Murillo Valles, Francisco Javier Arroyo Díez, Jesús González de Buitrago, José Luis Lechuga Campoy, Alfonso Lechuga Sancho, Ramón Cañete Estrada, Lidia Castro Feijóo, Jesús Barreiro Conde, Paloma Cabanas Rodríguez, Jordi Bosch Muñoz, Alicia Cepedano Dans, Mª Teresa Muñoz Calvo, Julio Guerrero Fernández, Rafael Yturriaga Matarranz, Elena Gallego Gómez, Jaime Sánchez del Pozo, Purificación Ros Pérez, Joaquín Ramírez Fernández, Mª Dolores Rodríguez Arnao, Sánchez Amparo Rodríguez, Juan Pedro López Siguero, Maria Jose Martinez-Aedo Ollero, Antonio Gutiérrez Macias, José María Martos Tello, María Chueca Guindulain, Cristina Azcona Sanjulián, Pablo Guerrero, Isolina Riaño Galán, Sofía Quinteiro González, José Manuel Rial Rodríguez, Juan Pedro González Díaz, Rafael Espino Aguilar, Luis López-Canti, Raquel Monné Gelonch, Jesús Martín Calama, Lidia Blasco Gonzalez, José Juan Alcón Sáez, Amparo Plasencia Couchoud, Luis Castaño González, Pedro Martul Tobío, Itxaso Rica Etxebarría, Concepción Fernández Ramos, Mª. Zaragoza Lou Francés, Manuel Ruiz-Echarri Zalaya, Gloria Bueno Lozano
Primary Institution: Hospital de Sabadell, Corporació Parc Taulí, Institut Universitari Parc Taulí, Universitat Autònoma de Barcelona, Sabadell, Spain
Hypothesis
Does GnRHa treatment improve adult height in girls with idiopathic central precocious puberty?
Conclusion
GnRHa treatment helps preserve genetic growth potential in girls with idiopathic CPP.
Supporting Evidence
- The study included 465 girls diagnosed with idiopathic CPP, with 18.90% being adopted.
- Mean difference between adult height and target height was -1.5 cm.
- 41% of patients attained their target height.
- Mean increase in height after treatment was 12.08 cm.
Takeaway
This study shows that a medicine called triptorelin can help girls who grow up too fast to be as tall as they could be when they grow up.
Methodology
This was a prospective observational study analyzing data from girls diagnosed with idiopathic CPP treated with triptorelin, assessing their height and other growth metrics over time.
Potential Biases
Potential biases include reliance on historical controls and the assumption of equal genetic contributions in target height calculations.
Limitations
The study lacked a control group of untreated patients, and comparisons were made with historical cohorts, which may introduce bias.
Participant Demographics
The study included 465 girls diagnosed with idiopathic CPP, with 18.90% being adopted.
Statistical Information
Confidence Interval
95% CI: -2.56− -0.45 cm
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website